KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
3.980
+0.030 (0.76%)
Oct 30, 2025, 10:22 AM EDT - Market open
KORU Medical Systems Revenue
KORU Medical Systems had revenue of $10.19M in the quarter ending June 30, 2025, with 20.93% growth. This brings the company's revenue in the last twelve months to $36.85M, up 19.57% year-over-year. In the year 2024, KORU Medical Systems had annual revenue of $33.65M with 17.98% growth.
Revenue (ttm)
$36.85M
Revenue Growth
+19.57%
P/S Ratio
4.93
Revenue / Employee
$460,606
Employees
80
Market Cap
184.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.65M | 5.13M | 17.98% |
| Dec 31, 2023 | 28.52M | 621.63K | 2.23% |
| Dec 31, 2022 | 27.90M | 4.41M | 18.76% |
| Dec 31, 2021 | 23.49M | -686.27K | -2.84% |
| Dec 31, 2020 | 24.18M | 1.01M | 4.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
KRMD News
- 7 days ago - KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 - Business Wire
- 6 weeks ago - ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy - Business Wire
- 2 months ago - Cirtec Medical Announces Appointment of New Chief Executive Officer - GlobeNewsWire
- 3 months ago - KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance - Business Wire
- 3 months ago - KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 3 months ago - KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025 - Business Wire